SAN DIEGO, April 25, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX) will announce corporate and financialresults for the first quarter 2017 on Tuesday, May 9th after the market closes. Following the announcement, Orexigen will provide a business update and discuss the financial results in a live webcast and conference
The live call may be accessed by phone by calling (800) 708-4540 (domestic) or (847) 619-6397 (international), participant code 44748374. The webcast can be accessed live on the "Investors" section of the Orexigen web site at www.orexigen.com, and will be archived for 14 days following the call.
Jason KeyesChief Financial OfficerOrexigen Therapeutics, Inc. +email@example.com
Media Contact: Erika HackmannY&Rfirstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-and-discuss-first-quarter-2017-financial-results-on-may-9-2017-300445666.html
SOURCE Orexigen Therapeutics, Inc.
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All